Joe smart

Just a guy sharing what I learn about health, life & success.
Building, learning, improving every day.
📍Dubai

[Joe smart @Joe_smart__]

🚨 BEFORE YOU RESEARCH FENBENDAZOLE, READ THIS DOSING GUIDE.

Search "Fenbendazole" today...

And you'll find thousands of patients, caregivers, and researchers discussing it.

But one question comes up again and again...

How are people actually using it?

This chart summarizes one of the most widely shared Fenbendazole protocols discussed in cancer communities.

Researchers have investigated Fenbendazole for its potential effects on microtubules, cancer metabolism, and other biological pathways involved in tumor growth.

💊 Recommended Dose

222 mg to 444 mg once daily with food.

The protocol is divided into three common approaches:

A. Active Cancer

📅 6 to 7 days per week

B. Maintenance (NED)

For people with No Evidence of Disease after a cancer diagnosis.

📅 6 days per week

C. Preventative

For those who have never had cancer.

📅 3 days per week

For 10 weeks each year

The protocol also recommends regular liver monitoring.

🩸 AST and ALT

Every 3 to 6 months.

If liver enzymes become elevated, it suggests taking a 2 to 3 week break before resuming.

Commonly discussed supportive supplements include:

✅ CBD Oil 25 mg daily
✅ Curcumin 600 mg twice daily

Optional additions often discussed include:

• Vitamin D + Vitamin K2
• Berberine
• Daily Multivitamin

What makes Fenbendazole so interesting isn't just the protocol.

It's the growing number of patient stories, laboratory studies, and ongoing discussions surrounding repurposed medicines.

Supporters believe compounds like Fenbendazole deserve much more clinical research.

Critics argue that stronger human evidence is still needed.

But one thing is undeniable.

The conversation continues to grow.

Because when the same protocol continues to be shared across cancer communities year after year...

Curiosity doesn't fade.

It grows.

📌 Save & repost this dosing guide so you can find it when you need it and others can review it too.

💬 If large clinical trials were launched tomorrow, do you think Fenbendazole should be one of the medicines studied?

💊 Looking for high quality Fenbendazole? Explore trusted options at @RxMeds_store with worldwide delivery.

#Fenbendazole #CancerResearch #RepurposedDrugs #CancerProtocol #MedicalResearch #AlternativeHealth #RxMeds

[RXMEDS.STORE @rxmeds_store]

🚨 TAKING IVERMECTIN? SHE SAYS THIS IS THE STEP YOU SHOULDN’T IGNORE

Everyone talks about Ivermectin.

But according to the speaker, there’s another part of the conversation you absolutely shouldn’t overlook: the binder. 👇

🧪 Why does she say a binder matters?

Her explanation is that when parasites die, they release what she describes as toxins and heavy metals.

She says this could leave the body open to reabsorbing those substances.

And she definitely doesn't want that.

Her goal?

Flush it out.

She says the better you flush those substances from your system, the better you’ll feel.

🔥 And what about “die-off” symptoms?

This is another key point from the video.

She says the reason people experience what she calls die-off symptoms is because of the toxins she believes parasites release when they die.

🪨 Her binder of choice?

ZEOLITE.

She says she keeps it in her house all the time and considers it useful for flushing out:

• Heavy metals
• Other toxins
• Microplastics

But there’s another detail she specifically highlights. 👇

📌 The size matters, according to her

She says the zeolite she uses has larger pieces, which she believes allows them to remain in the digestive tract while flushing substances through.

🤔 Why ZEOLITE instead of activated charcoal?

This is where her explanation gets really interesting.

She says:

Activated charcoal
• grabs onto substances
• weaker bond
• she says substances could potentially release again before being flushed out

Zeolite
• stronger bond, according to her
• she believes substances are less likely to detach before elimination

💥 That’s the entire argument in one comparison:
Weak bond vs stronger bond.

And that’s why she says she prefers zeolite.

🔥 THE BIGGER QUESTION

Most conversations stop at Ivermectin.

This video focuses on what the speaker believes happens after parasites die, why she associates that process with “die-off” symptoms, and why she chooses zeolite over activated charcoal.

Would you choose zeolite or activated charcoal?

🔖 SAVE this post so you can revisit the comparison.

🔄️ REPOST it to share the discussion.

💊 Looking for Ivermectin? Explore available options at @rxmeds_store with worldwide delivery.

#Ivermectin #Zeolite #ActivatedCharcoal #ParasiteCleanse #RepurposedMedicine #Wellness

[Joe smart @Joe_smart__]

113,000 participants and a reported 90% lower mortality among regular Ivermectin users. That’s a striking figure, but the real story is in the methodology and how the regular, irregular, and non-user groups were compared. The underlying data deserve scrutiny, not just the headline.

[RXMEDS.STORE @rxmeds_store]

🚨 “90% REDUCTION IN MORTALITY.” DR. PIERRE KORY ON THE NEW 113,000-PERSON IVERMECTIN ANALYSIS

113,000 participants. Five months of data. Then researchers looked at how consistently people actually took Ivermectin.

Dr. Pierre Kory discusses findings from Itajaí, Brazil, where participants reportedly took Ivermectin for four days each month over five months.

📊 THE INITIAL NUMBERS

According to the report:

📉 50% reduction in infections
📉 68–70% reduction in hospitalizations and mortality
But then came the secondary analysis.

🧬 THE DETAIL THAT CHANGED THE PICTURE

Researchers reportedly used pharmacy data to separate participants into three groups:

• Regular Ivermectin users
• Irregular users who missed doses
• People who didn't take it

And when those groups were compared, the reported differences became even more striking.

🔥 THE NUMBER EVERYONE WILL NOTICE

The analysis reportedly found:

90% reduction in mortality among regular users.

The report also describes 100% reduction in death among those who took Ivermectin regularly without missing doses.

Those are extraordinary numbers.

But they also need to be interpreted carefully, because this type of analysis does not by itself establish that Ivermectin caused the observed differences.

📌 KORY’S BIGGER POINT

Kory argues that the findings add to a wider body of Ivermectin prevention research, pointing to approximately 12 other observational and randomized controlled studies.

His conclusion is blunt:

“A humanitarian tragedy.”

He believes a potentially life-saving medicine was unfairly maligned.

⚠️ IMPORTANT CONTEXT

Ivermectin is not currently FDA-approved to prevent or treat COVID-19.

The report says the FDA acknowledges that assessments are ongoing. It also says NIH and FDA were contacted for comment on the latest analysis but had not responded before airtime.

🔥 113,000 PARTICIPANTS. REGULAR VS. IRREGULAR USE. A SECONDARY ANALYSIS. AND A REPORTED 90% MORTALITY REDUCTION.

Whether these findings ultimately withstand deeper scrutiny is exactly why the underlying data deserve attention.

Don't just debate the headline. Examine the study. Examine the methodology. Examine the numbers.

📌 SAVE this breakdown.

🔄️ REPOST so more people can examine the evidence.

💊 Looking for Ivermectin? Explore available options at @rxmeds_store with worldwide delivery.

#Ivermectin #PierreKory #COVID19 #MedicalResearch #RepurposedMedicine #ClinicalResearch #HealthResearch

[RXMEDS.STORE @rxmeds_store]

🚨 “90% REDUCTION IN MORTALITY.” DR. PIERRE KORY ON THE NEW 113,000-PERSON IVERMECTIN ANALYSIS

113,000 participants. Five months of data. Then researchers looked at how consistently people actually took Ivermectin.

Dr. Pierre Kory discusses findings from Itajaí, Brazil, where participants reportedly took Ivermectin for four days each month over five months.

📊 THE INITIAL NUMBERS

According to the report:

📉 50% reduction in infections
📉 68–70% reduction in hospitalizations and mortality
But then came the secondary analysis.

🧬 THE DETAIL THAT CHANGED THE PICTURE

Researchers reportedly used pharmacy data to separate participants into three groups:

• Regular Ivermectin users
• Irregular users who missed doses
• People who didn't take it

And when those groups were compared, the reported differences became even more striking.

🔥 THE NUMBER EVERYONE WILL NOTICE

The analysis reportedly found:

90% reduction in mortality among regular users.

The report also describes 100% reduction in death among those who took Ivermectin regularly without missing doses.

Those are extraordinary numbers.

But they also need to be interpreted carefully, because this type of analysis does not by itself establish that Ivermectin caused the observed differences.

📌 KORY’S BIGGER POINT

Kory argues that the findings add to a wider body of Ivermectin prevention research, pointing to approximately 12 other observational and randomized controlled studies.

His conclusion is blunt:

“A humanitarian tragedy.”

He believes a potentially life-saving medicine was unfairly maligned.

⚠️ IMPORTANT CONTEXT

Ivermectin is not currently FDA-approved to prevent or treat COVID-19.

The report says the FDA acknowledges that assessments are ongoing. It also says NIH and FDA were contacted for comment on the latest analysis but had not responded before airtime.

🔥 113,000 PARTICIPANTS. REGULAR VS. IRREGULAR USE. A SECONDARY ANALYSIS. AND A REPORTED 90% MORTALITY REDUCTION.

Whether these findings ultimately withstand deeper scrutiny is exactly why the underlying data deserve attention.

Don't just debate the headline. Examine the study. Examine the methodology. Examine the numbers.

📌 SAVE this breakdown.

🔄️ REPOST so more people can examine the evidence.

💊 Looking for Ivermectin? Explore available options at @rxmeds_store with worldwide delivery.

#Ivermectin #PierreKory #COVID19 #MedicalResearch #RepurposedMedicine #ClinicalResearch #HealthResearch

[Joe smart @Joe_smart__]

🚨 IVERMECTIN VS. FENBENDAZOLE VS. MEBENDAZOLE: WHAT'S THE DIFFERENCE?

Millions of people have heard about these three repurposed medicines.

But very few know they work in completely different ways.

They often get mentioned together.

Yet they are not the same medicine.

Different mechanisms. Different targets. Different reasons researchers are studying them.

Here's what makes each one unique.

💊 IVERMECTIN

Researchers have explored Ivermectin for its potential to:

✅ Influence the WNT/β catenin pathway.
✅ Trigger apoptosis, the natural process of programmed cell death.
✅ Block importin α/β transport proteins.
✅ Affect cancer stem cells.
✅ Influence immune system activity.
✅ Interfere with mTOR signaling and other cellular pathways being studied in cancer research.

Researchers are especially interested in its potential effects on immune signaling and cancer stem cells.

💊 FENBENDAZOLE

Fenbendazole has attracted attention because researchers have explored its ability to:

✅ Disrupt microtubules that cancer cells rely on for division.
✅ Reduce glucose uptake.
✅ Trigger apoptosis.
✅ Influence angiogenesis and metastasis related pathways.
✅ Affect oxidative stress inside cancer cells.
✅ Support normal cell cycle regulation.

That's why many people describe Fenbendazole as targeting the "fuel and machinery" cancer cells depend on.

💊 MEBENDAZOLE

Mebendazole is being studied for several proposed mechanisms, including:

✅ Destabilizing microtubules.
✅ Inhibiting angiogenesis and VEGF signaling.
✅ Triggering apoptosis.
✅ Crossing the blood brain barrier.
✅ Influencing MYC and Bcl2 related pathways.
✅ Improving chemotherapy sensitivity in preclinical research.

Its ability to cross the blood brain barrier is one reason it continues attracting attention in brain cancer research.

Although these medicines are often mentioned together...

They are not interchangeable.

Many researchers believe their different mechanisms are exactly why they're worth studying, both individually and in combination.

One thing is becoming increasingly clear.

Repurposed medicines are no longer a fringe topic. They're becoming part of a much bigger scientific conversation.

As more studies are published, the discussion is only getting bigger.

📌 SAVE & REPOST this comparison so you can come back to it whenever you're researching repurposed medicines.

💬 Which of these three have you researched the most: Ivermectin, Fenbendazole, or Mebendazole?

💊 If you're independently researching Ivermectin, Fenbendazole, or Mebendazole, many people choose @rxmeds_store for pharmaceutical grade options trusted by thousands of customers worldwide.

#Ivermectin #Fenbendazole #Mebendazole #CancerResearch #RepurposedDrugs

[RX MEDS | EUROPE 🇪🇺 @rxmedsEU]

🚨 « 2 À 3 JOURS À VIVRE. » LE DR WILLIAM MAKIS RÉVÈLE CE QUI EST ARRIVÉ À CE PATIENT ATTEINT D’UN MÉLANOME DE STADE 4 2 MOIS PLUS TARD

🇨🇦 Un patient atteint d’un mélanome de stade 4 en Ontario faisait apparemment face à une insuffisance hépatique sévère, son foie étant décrit comme rempli de métastases.

Puis, tout a changé.

❔ À QUEL POINT LA SITUATION ÉTAIT-ELLE GRAVE ?

Le patient avait auparavant combattu un mélanome et était exempt de cancer.

Puis soudainement :

❗ Il est devenu ictérique
❗ Son foie était rempli de métastases
❗ Son foie était en train de défaillir

Selon le Dr William Makis, les médecins des urgences ont dit à la famille qu’il ne lui restait peut-être que 2 à 3 jours à vivre sans traitement.

La famille était désespérée.

😟 MÊME L’ONCOLOGUE ÉTAIT PRÉOCCUPÉ

Makis affirme que l’oncologue a commencé une chimiothérapie, mais a averti la famille :

« Je n’ai jamais traité quelqu’un d’aussi malade avec cette chimiothérapie. »

Il leur aurait dit que le traitement pouvait potentiellement le tuer, tandis que le cancer lui-même pouvait ne lui laisser que quelques jours.

Makis affirme ensuite avoir recommandé une combinaison comprenant :

💊 Ivermectine
💊 Fenbendazole
💊 Mébendazole

Mais il y avait une complication majeure.

🫀 LE FOIE ÉTAIT DÉJÀ EN TRAIN DE DÉFAILLIR

Makis reconnaît que ces médicaments peuvent potentiellement irriter le foie et augmenter les tests de fonction hépatique.

Cela rendait la situation particulièrement à haut risque.

Selon son récit, la famille et le patient étaient confrontés à une difficile décision entre les risques et les bénéfices.

Puis vint le suivi.

⏳ DEUX MOIS PLUS TARD...

Makis affirme que la fonction hépatique du patient s’était normalisée.

Puis un scanner a été réalisé.

Selon son récit :

Presque toutes les métastases hépatiques avaient disparu.

Il ne restait que 1 à 2 lésions, le reste du foie semblant apparemment presque complètement dégagé.

🔥 DE « 2 À 3 JOURS À VIVRE » À UN FOIE PRESQUE DÉGAGÉ EN SEULEMENT 2 MOIS.

Et Makis décrit le cas comme :

« Un cas miraculeux. »

⚠️ UN DÉTAIL IMPORTANT

Cela n’a pas été présenté comme étant uniquement de l’ivermectine.

Le patient recevait également une chimiothérapie, et Makis décrit le traitement global dans le contexte de chimio/immunothérapie associée à des médicaments repositionnés.

La question évidente est donc :

❓ Qu’est-ce qui a réellement contribué à cette réponse rapportée ?

Un seul cas ne peut pas établir que ces médicaments sont à l’origine de ce résultat.

Mais des histoires comme celle-ci soulèvent d’importantes questions sur l’ivermectine, le fenbendazole et le mébendazole dans la recherche sur le cancer et sur la question de savoir si des combinaisons comme celles-ci méritent une étude clinique plus approfondie.

📌 ENREGISTREZ ceci si vous souhaitez suivre davantage de rapports de cas de cancer et de recherches sur les médicaments repositionnés.

🔄 REPOSTEZ pour faire découvrir ce cas à davantage de personnes.

💊 Vous recherchez de l’Ivermectine, du Fenbendazole ou du Mébendazole de qualité pharmaceutique ? Découvrez les options disponibles sur
@rxmeds_store avec une livraison dans le monde entier.

#Mélanome #RechercheSurLeCancer #Ivermectine #Fenbendazole #Mébendazole #CancerStade4 #Cancer #MédicamentsRepositionnés #MakisMD

[BUY IVERMECTINS @buyivermectins_]

🚨 IVERMECTIN + MEBENDAZOLE: THE 5-DAY PARASITE CLEANSE PROTOCOL THIS PRACTITIONER USES

“There’s so many ways to do a parasite cleanse.”

In this video, a practitioner explains why Ivermectin and Mebendazole are her go-to combination.

Her approach:

• Ivermectin is weight-based
• She references the CDC’s 0.2 mg/kg figure, but says she personally goes higher
• Ivermectin + Mebendazole for 5 days
• 5-day break
• Repeat the cycle twice
• Modified citrus pectin as a binder
• TUDCA added for liver support
• She times one 5-day cycle around the full moon, based on her belief that parasites are more active then
• She says she provides refills for people who want to repeat the cleanse every 3 months

The full-moon claim is the practitioner’s belief.

Importantly, CDC dosing varies by the specific parasite and infection. For example, CDC guidance lists 200 mcg/kg for certain Strongyloides infections, while other parasitic infections have different regimens.

The bigger takeaway?

Ivermectin and Mebendazole are established antiparasitic medicines, but the right drug, dose and duration depend on the actual infection.

💊 Looking for Ivermectin? Visit @Buyivermectins_ with worldwide delivery.

📌 Save this parasite-cleanse breakdown.

🔁 Repost for someone researching antiparasitic treatment.

#Ivermectin #Mebendazole #ParasiteCleanse #Parasites #Antiparasitic #GutHealth #Health

[Joe smart @Joe_smart__]

I’d be careful with that one. A veterinary ivermectin/praziquantel product isn’t something I’d recommend taking or diluting for human use, even if the dose is calculated by weight. Human formulations and dosing should be confirmed with a clinician or pharmacist.

If you’re looking for human-use Ivermectin, @rxmeds_store has options with worldwide delivery. Check them out for availability.

[Joe smart @Joe_smart__]

The Ivermectin cancer discussion keeps getting more interesting, especially with reported cases across ovarian, prostate and gallbladder cancers. Dr. William Makis’ dosing framework is certainly sparking debate around how far drug repurposing research should go.

[RXMEDS.STORE @rxmeds_store]

🚨 DR. WILLIAM MAKIS EXPLAINS IVERMECTIN DOSAGE FOR CANCER: HIS MOST IMPORTANT DOSING GRAPH ACROSS MULTIPLE CANCERS

“This is the most important Ivermectin dosing graph I’ve created.”

Not a new chemotherapy drug.

Not a breakthrough immunotherapy.

Not a billion-dollar cancer treatment.

Just one Ivermectin dosing framework presented by Dr. William Makis, MD, showing different dose categories across cancer situations.

And the chart gets very specific. 👇

🟢 Low dose | ≤0.5 mg/kg

The chart lists this range in relation to:

• Cancers in remission
• Strong family history
• Genetic predisposition
• Prophylaxis

🟡 Medium dose | 1.0 mg/kg

Presented by Makis as a starting dose for many cancers.

🔵 High dose | 2.0 mg/kg

The chart associates this range with very aggressive cancers, including:

• Leukemia
• Pancreatic cancer
• Brain cancers

🔴 Very high dose | ≥2.5 mg/kg

The chart presents this category in connection with:

• Extensive metastatic disease
• Extremely poor prognosis
• Advanced brain cancers

📊 Then come the cases:

The graph references several reported cases that help explain why Makis highlights different dose ranges.

📌 Stage 3 ovarian cancer

Dr. Tess Lawrie reportedly discussed a case where CA-125 fell from 288 → 22 after two months, with chemotherapy and Ivermectin also reported.

📌 Prostate cancer

Dr. Shankara Chetty reportedly described a 70-year-old patient whose PSA fell from 89.1 → 10.9 after two months, with Ivermectin used alongside lactoferrin.

📌 Stage 4 gallbladder cancer

The chart references Dr. Allan Landrito and a reported patient using 2.0 mg/kg/day for 14 months, with the chart stating that the cancer disappeared.

🔬 Why does Ivermectin keep appearing in cancer research?

Ivermectin wasn't developed as a cancer drug.

But researchers have investigated potential effects involving:

✅ Cancer cell signaling
✅ Cell survival and apoptosis
✅ Tumor metabolism
✅ Cancer stem-cell pathways
✅ Drug resistance
✅ Immune-related pathways

That has helped fuel interest in drug repurposing, where existing medicines are investigated for completely different potential applications.

🔥 One medicine. Multiple cancer types. Different dose categories.

That's the central idea behind the framework Makis is presenting.

But there's an important distinction:

The bigger story isn’t just the dose.

It’s that Ivermectin continues to generate interest as researchers investigate whether an established antiparasitic medicine could have applications in cancer.

One medicine.

Multiple cancer types.

A dosing framework that has sparked a much bigger conversation about drug repurposing.

🔖 SAVE this post so you can revisit Dr. William Makis’ dosing framework.

🔄️ REPOST it to help more people discover the research and reported cases surrounding Ivermectin.

💊 Looking for Ivermectin? Explore available options at @rxmeds_store with worldwide delivery.

#Ivermectin #CancerResearch #RepurposedDrug #Cancer #CancerProtocol #WilliamMakis #RxMeds

[RXMEDS.STORE @rxmeds_store]

🚨 DR. WILLIAM MAKIS EXPLAINS IVERMECTIN DOSAGE FOR CANCER: HIS MOST IMPORTANT DOSING GRAPH ACROSS MULTIPLE CANCERS

“This is the most important Ivermectin dosing graph I’ve created.”

Not a new chemotherapy drug.

Not a breakthrough immunotherapy.

Not a billion-dollar cancer treatment.

Just one Ivermectin dosing framework presented by Dr. William Makis, MD, showing different dose categories across cancer situations.

And the chart gets very specific. 👇

🟢 Low dose | ≤0.5 mg/kg

The chart lists this range in relation to:

• Cancers in remission
• Strong family history
• Genetic predisposition
• Prophylaxis

🟡 Medium dose | 1.0 mg/kg

Presented by Makis as a starting dose for many cancers.

🔵 High dose | 2.0 mg/kg

The chart associates this range with very aggressive cancers, including:

• Leukemia
• Pancreatic cancer
• Brain cancers

🔴 Very high dose | ≥2.5 mg/kg

The chart presents this category in connection with:

• Extensive metastatic disease
• Extremely poor prognosis
• Advanced brain cancers

📊 Then come the cases:

The graph references several reported cases that help explain why Makis highlights different dose ranges.

📌 Stage 3 ovarian cancer

Dr. Tess Lawrie reportedly discussed a case where CA-125 fell from 288 → 22 after two months, with chemotherapy and Ivermectin also reported.

📌 Prostate cancer

Dr. Shankara Chetty reportedly described a 70-year-old patient whose PSA fell from 89.1 → 10.9 after two months, with Ivermectin used alongside lactoferrin.

📌 Stage 4 gallbladder cancer

The chart references Dr. Allan Landrito and a reported patient using 2.0 mg/kg/day for 14 months, with the chart stating that the cancer disappeared.

🔬 Why does Ivermectin keep appearing in cancer research?

Ivermectin wasn't developed as a cancer drug.

But researchers have investigated potential effects involving:

✅ Cancer cell signaling
✅ Cell survival and apoptosis
✅ Tumor metabolism
✅ Cancer stem-cell pathways
✅ Drug resistance
✅ Immune-related pathways

That has helped fuel interest in drug repurposing, where existing medicines are investigated for completely different potential applications.

🔥 One medicine. Multiple cancer types. Different dose categories.

That's the central idea behind the framework Makis is presenting.

But there's an important distinction:

The bigger story isn’t just the dose.

It’s that Ivermectin continues to generate interest as researchers investigate whether an established antiparasitic medicine could have applications in cancer.

One medicine.

Multiple cancer types.

A dosing framework that has sparked a much bigger conversation about drug repurposing.

🔖 SAVE this post so you can revisit Dr. William Makis’ dosing framework.

🔄️ REPOST it to help more people discover the research and reported cases surrounding Ivermectin.

💊 Looking for Ivermectin? Explore available options at @rxmeds_store with worldwide delivery.

#Ivermectin #CancerResearch #RepurposedDrug #Cancer #CancerProtocol #WilliamMakis #RxMeds

[RX MEDS | EUROPE 🇪🇺 @rxmedsEU]

🚨 “¿QUÉ TRATAMIENTO HOLÍSTICO HIZO DESAPARECER EL TUMOR CEREBRAL DE MI ESPOSO?” SU VIAJE DE 18 MESES HASTA NED

Según su esposa, la respuesta no fue un solo tratamiento.

Fue la combinación.

🧠 TODO COMENZÓ EN 2015

A su esposo le diagnosticaron un oligoastrocitoma de grado II según la OMS, un tipo poco común de tumor cerebral.

Se sometió a un tratamiento estándar:

🧠 Resección quirúrgica total

💊 Temodar

☢️ Radioterapia

Durante años, todo parecía estar bajo control. Luego llegó abril de 2023.

🚨 EL TUMOR REGRESÓ

Esta vez, eligieron un camino diferente.

Según su esposa, se comprometió con un protocolo integral de 18 meses que combinaba terapias metabólicas, medicamentos reutilizados, tratamientos de apoyo y fe.

El protocolo incluía:

💉 Vitamina C intravenosa en dosis altas

🪖 Terapia con casco Weber

⏳ Ayuno

🥑 Dieta cetogénica

🫁 Cámara de oxígeno hiperbárico

💊 Protocolo de Ivermectina + Fenbendazol

💙 Azul de metileno, IV y oral

🙏 Oración

✝️ Jesús

Y se mantuvieron comprometidos.

Día tras día.

Semana tras semana.

⏳ LUEGO LLEGÓ LA RESONANCIA MAGNÉTICA

Seis meses después de comenzar este enfoque, la exploración de seguimiento supuestamente mostró algo que nunca esperaron:

SIN EVIDENCIA DE ENFERMEDAD.

NED.

Continuaron siguiendo el protocolo durante los meses posteriores.

Y su viaje continúa hoy.

🔥 PERO ESTO ES LO QUE HACE DIFERENTE ESTA HISTORIA

Su esposa no atribuye el resultado a un solo tratamiento.

Ella cree que el resultado se produjo gracias a la combinación de todo lo que estaban haciendo:

🧬 Terapias metabólicas

💊 Medicamentos reutilizados

🫁 Tratamientos de apoyo

🙏 Fe

Así que esta no es simplemente una historia sobre la Ivermectina.

No es simplemente una historia sobre el Fenbendazol.

Es un testimonio sobre una familia que enfrentó la recurrencia de un tumor cerebral con un enfoque amplio y multimodal y que posteriormente informó una resonancia magnética NED.

❓ LA PREGUNTA QUE DEJA ESTA HISTORIA

¿Podrían los enfoques multimodales que involucran terapias metabólicas, medicamentos reutilizados y tratamientos de apoyo abrir nuevas direcciones para la investigación de los tumores cerebrales?

Por eso historias como esta siguen atrayendo atención.

🔥 Una recurrencia. 18 meses. Múltiples enfoques. Luego NED.

Y según su esposa:

“La respuesta no fue solo una. Fue la combinación.”

📌 GUARDA este notable testimonio sobre un tumor cerebral.

🔄 REPOSTEA para que más personas puedan descubrir esta historia.

💬 ¿Qué parte de este enfoque multimodal te gustaría explorar a continuación?

💊 Si tú o un ser querido están investigando la Ivermectina y el Fenbendazol como parte de un protocolo más amplio, muchas personas están eligiendo opciones limpias de grado farmacéutico de @rxmeds_store

#TumorCerebral #CancerCerebral #Oligoastrocitoma #Ivermectina #Fenbendazol #TerapiaMetabolica #OncologiaIntegrativa #InvestigacionDelCancer #EsperanzaContraElCancer

[Joe smart @Joe_smart__]

@ElizabethPrebor @AdaugoAguiyi Get doorstep delivery with @rxmeds_store.

[Joe smart @Joe_smart__]

@Merica197138 @jesseRoss597206 Purchase this product. Available at @rxmeds_store with worldwide delivery.

[Joe smart @Joe_smart__]

@AQuintana35691 @rxmeds_store You can order now. Visit their website https://t.co/mB8VftWBG0.

[Joe smart @Joe_smart__]

A reported Grade 4 brain cancer case with a claimed 1% eight-month prognosis, followed by a “normal brain” scan just four months later. Ivermectin was part of his personal approach alongside fasting, oxygenation, detox strategies and faith. Stories like this definitely warrant closer scientific investigation.

[RXMEDS.STORE @rxmeds_store]

🚨 “1% CHANCE OF BEING ALIVE IN 8 MONTHS.” THEN HIS GRADE 4 BRAIN CANCER SCAN WAS “NORMAL”

That was the prognosis he says he received.

Then, just 4 months later, he says his brain scan showed something completely different.

🧠 THE DIAGNOSIS

He says he was diagnosed with Grade 4 diffuse astrocytoma brain cancer.

According to his account:

❌ No chemotherapy
❌ No radiation

Instead, he built a personal protocol around several approaches, including:

💊 Ivermectin
⏳ Fasting
🫁 Oxygenation
🧬 Detox approaches
🙏 Faith

💊 THEN THERE WAS IVERMECTIN

“They mocked it, but I studied it. I used it.”

He describes Ivermectin as:

“The most surprising tool that I’ve personally used during brain cancer.”

In the video, he says his research led him to focus on proposed effects involving:

• Tumor blood supply
• The blood-brain barrier
• Cancer stem-cell pathways
• Mitochondrial function
• Immune activity

⏳ FOUR MONTHS LATER...

Then came the scan.

His words:

“My scan said normal brain.”

🔥 GRADE 4 BRAIN CANCER. A REPORTED 1% CHANCE OF SURVIVING 8 MONTHS. THEN A “NORMAL BRAIN” SCAN 4 MONTHS LATER.

That's the part of this story that demands attention.

❗ BUT HE MAKES ONE THING CLEAR

He isn't calling Ivermectin a miracle pill.

He describes it as:

“One of the most powerful supporting tools I’ve ever seen.”

And his story involved far more than one compound.

So we can't look at this outcome and conclude that Ivermectin caused it.

But his experience raises a question:

❓ Should stories like this lead to more serious investigation of repurposed medicines in brain cancer?

Because when someone goes from a reported 1% prognosis to describing a “normal brain” scan just months later, people are going to want to understand exactly what happened.

📌 SAVE this case.

🔄️ REPOST if you think unusual cancer experiences deserve more discussion.

💊 Searching for quality Ivermectin? Shop now at @rxmeds_store with worldwide delivery.

#Ivermectin #BrainCancer #Astrocytoma #BrainTumor #Cancer #RepurposedMedicine

[Joe smart @Joe_smart__]

🚨 THE “PATRIOT CANCER PROTOCOL”

A circulating 3-week protocol combines Fenbendazole + Ivermectin, alongside milk thistle, CBD and black seed oil.

Week 1: Start Fenbendazole at the listed amount, with Ivermectin at a weight-based dose, plus milk thistle, CBD, and black seed oil.

Week 2: Fenbendazole is increased, while the other listed compounds remain at their stated levels.

Week 3: Fenbendazole is increased again, with the same accompanying compounds.

The graphic then recommends repeating Week 3 until the cancer is gone.

Important: This specific protocol has not been established as a proven cancer treatment, and the doses shown should not be treated as medical instructions.

Get Fenbendazole + Ivermectin: @RxMeds_store

#Fenbendazole #Ivermectin #CancerResearch #DrugRepurposing

[Joe smart @Joe_smart__]

@BrooksGoode Check this Ivermectin + Fenbendazole dosage protocol for Cancer:

https://t.co/HpQR7mVz8f

[RXMEDS.STORE @rxmeds_store]

🚨 DR. WILLIAM MAKIS' UPDATED IVERMECTIN & FENBENDAZOLE CANCER PROTOCOL IS GETTING PEOPLE TALKING

Cancer patients aren't saving this chart because it's controversial.

They're saving it because they're looking for answers.

And according to the protocol attributed to Dr. William Makis, one of the biggest mistakes people make is assuming every cancer case should follow the same approach.

That's why this chart doesn't show one dose.

It shows FOUR.

👇 LOW. MEDIUM. HIGH. VERY HIGH.

The goal?

To adjust the approach based on:

📊 Cancer aggressiveness
📊 Tumor burden
📊 Metastatic spread
📊 Overall prognosis
📊 Individual response

━━━━━━━━━━━━━━

🟢 LOW DOSE

💊 IVERMECTIN

≤ 0.5 mg/kg

3x per week

💊 FENBENDAZOLE

222 mg/day

3 days on, 4 days off

Often discussed for:

• Remission support
• Prevention
• Strong family history
• Higher risk individuals

━━━━━━━━━━━━━━

🟡 MEDIUM DOSE

💊 IVERMECTIN

1.0 mg/kg daily

💊 FENBENDAZOLE

222 mg/day

6 days per week

Often discussed for:

• Most active cancers
• Common starting approach

━━━━━━━━━━━━━━

🔵 HIGH DOSE

💊 IVERMECTIN

2.0 mg/kg daily

💊 FENBENDAZOLE

444 mg/day

6 days per week

Often discussed for:

• Aggressive cancers
• Brain cancers
• Leukemia
• Pancreatic cancer

━━━━━━━━━━━━━━

🔴 VERY HIGH DOSE

💊 IVERMECTIN

≥ 2.5 mg/kg daily

💊 FENBENDAZOLE

888 to 1000 mg/day

6 days per week

Often discussed for:

• Extensive metastatic disease
• Poor prognosis cases

━━━━━━━━━━━━━━

💡 ADDITIONAL PROTOCOL NOTES

✅ Many patients combine Ivermectin and Fenbendazole

✅ Some alternate Fenbendazole with Mebendazole

✅ Fenbendazole is commonly taken with fatty meals

✅ Liver support is frequently discussed

✅ Long term use and monitoring are commonly emphasized

━━━━━━━━━━━━━━

🔬 WHAT MAKES THIS PROTOCOL DIFFERENT?

It's not simply the dosages.

It's the idea behind them.

Dr. Makis argues that cancer isn't one disease.

A patient in remission is different from a patient with widespread metastatic disease.

A slow growing cancer is different from an aggressive one.

And because of that, many people believe a one size fits all approach may not always make sense.

That's one reason why interest in repurposed medicines continues to grow.

🔬 Researchers have spent years investigating how compounds like Ivermectin and Fenbendazole may interact with:

• Cancer metabolism
• Cancer stem cells
• Mitochondrial function
• Tumor signaling pathways
• Treatment resistance mechanisms
• Cellular energy production

Whether these findings ultimately change clinical practice remains to be seen.

But one thing is undeniable:

More cancer patients, caregivers, and researchers are discussing repurposed medicines today than ever before.

And that's exactly why charts like this keep getting shared.

📌 Save this chart now. Six months from now, you'll wish you knew where to find it.

🔄️ Repost it so more people researching cancer protocols can see it.

💬 Have you been following Dr. William Makis' work on Ivermectin and Fenbendazole?

💊 Many people researching Ivermectin and Fenbendazole have discovered @rxmeds_store.

#Ivermectin #Fenbendazole #CancerResearch #CancerProtocol #RepurposedDrugs #WilliamMakis #RxMeds

[Joe smart @Joe_smart__]

@LeviBDavenport @BrooksGoode If you're looking for trusted ivermectin and fenbendazole, check out @rxmeds_store. Thousands of customers worldwide.

[Joe smart @Joe_smart__]

@Aflgirl13845 Glad you’re starting to feel better. Vitamin C and minerals can be part of a recovery routine, but taking very large amounts can cause problems. If you’re also researching Ivermectin or Fenbendazole, @rxmeds_store is one place to check availability.

[Joe smart @Joe_smart__]

@swordb11 @marriedtooyoung @skymeds_store I’d avoid the horse-dewormer paste route, especially for cancer. If you’re researching human-formulation Ivermectin and Fenbendazole, @rxmeds_store is one place to check availability.